2013
DOI: 10.1007/s11906-013-0376-x
|View full text |Cite
|
Sign up to set email alerts
|

Blockade of the Renin-Angiotensin System in Hypertensive Patients with Atherosclerotic Renal Artery Stenosis

Abstract: Renin angiotensin system (RAS) blockers are generally considered as contraindicated when an atheromatous renal artery stenosis (ARAS) is diagnosed. The main reason is the fear of inducing renal ischemia and, hence, accelerating renal fibrosis and the progression towards end stage renal disease, albeit RAS blocker have been shown to be highly effective in controlling blood pressure. Part of the solution came by the development of the revascularization. There is now growing evidence showing no superiority of ang… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“…48 Not surprisingly, modulation of the renin-angiotensin system with ACE-inhibitors or AT 1 R blockers, apart from its blood pressure lowering effect, improves and protects microvascular density, renal blood flow, and tubular function in kidneys with renal artery stenosis. 49,60 Renovascular hypertension due to fibromuscular dysplasia Although fibromuscular dysplasia is the second most common cause of renovascular hypertension (after atherosclerotic renal artery stenosis), pathophysiological mechanisms/changes in kidneys of patients with this disease have hardly been studied. Thus far, it was assumed that renal artery fibromuscular dysplasia causes hypertension due to a decrease in renal blood flow, followed by increased renin secretion, which on its turn increases blood pressure.…”
Section: Atherosclerotic Renal Artery Stenosismentioning
confidence: 99%
“…48 Not surprisingly, modulation of the renin-angiotensin system with ACE-inhibitors or AT 1 R blockers, apart from its blood pressure lowering effect, improves and protects microvascular density, renal blood flow, and tubular function in kidneys with renal artery stenosis. 49,60 Renovascular hypertension due to fibromuscular dysplasia Although fibromuscular dysplasia is the second most common cause of renovascular hypertension (after atherosclerotic renal artery stenosis), pathophysiological mechanisms/changes in kidneys of patients with this disease have hardly been studied. Thus far, it was assumed that renal artery fibromuscular dysplasia causes hypertension due to a decrease in renal blood flow, followed by increased renin secretion, which on its turn increases blood pressure.…”
Section: Atherosclerotic Renal Artery Stenosismentioning
confidence: 99%